228 related articles for article (PubMed ID: 9690966)
1. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome.
Tamminga CA; Buchanan RW; Gold JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S21-6. PubMed ID: 9690966
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
Hill SK; Keshavan MS; Thase ME; Sweeney JA
Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687
[TBL] [Abstract][Full Text] [Related]
3. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
4. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
[TBL] [Abstract][Full Text] [Related]
5. Lifelong course of positive and negative symptoms in chronically institutionalized patients with schizophrenia.
Mancevski B; Keilp J; Kurzon M; Berman RM; Ortakov V; Harkavy-Friedman J; Rosoklija G; Dwork AJ
Psychopathology; 2007; 40(2):83-92. PubMed ID: 17215594
[TBL] [Abstract][Full Text] [Related]
6. Novel antipsychotics and negative symptoms.
Möller HJ
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S43-7. PubMed ID: 9690970
[TBL] [Abstract][Full Text] [Related]
7. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
Lecardeur L; Meunier-Cussac S; Dollfus S
Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia.
Gold S; Arndt S; Nopoulos P; O'Leary DS; Andreasen NC
Am J Psychiatry; 1999 Sep; 156(9):1342-8. PubMed ID: 10484943
[TBL] [Abstract][Full Text] [Related]
9. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
[TBL] [Abstract][Full Text] [Related]
10. Correlates, change and 'state or trait' properties of insight in schizophrenia.
Wiffen BD; Rabinowitz J; Lex A; David AS
Schizophr Res; 2010 Sep; 122(1-3):94-103. PubMed ID: 20382507
[TBL] [Abstract][Full Text] [Related]
11. Depressive symptoms and schizophrenia a psychopharmacological approach.
Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
[TBL] [Abstract][Full Text] [Related]
12. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
13. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
Feldman PD; Kaiser CJ; Kennedy JS; Sutton VK; Tran PV; Tollefson GD; Zhang F; Breier A
J Clin Psychiatry; 2003 Sep; 64(9):998-1004. PubMed ID: 14628974
[TBL] [Abstract][Full Text] [Related]
14. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.
Ho BC; Andreasen NC; Flaum M; Nopoulos P; Miller D
Am J Psychiatry; 2000 May; 157(5):808-15. PubMed ID: 10784476
[TBL] [Abstract][Full Text] [Related]
15. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness.
Haas GL; Garratt LS; Sweeney JA
J Psychiatr Res; 1998; 32(3-4):151-9. PubMed ID: 9793868
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and treatment of negative symptoms.
Villeneuve A
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
[TBL] [Abstract][Full Text] [Related]
20. [Methodological constraints in evaluating anti-deficit effects].
Boyer P; Lecrubier Y; Rein W
Encephale; 1996 Jun; 22 Spec No 2():25-7. PubMed ID: 8767038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
